- Home
- RLGT vs XOMA Comparison
RLGT vs XOMA Comparison
Compare RLGT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- XOMA
- Stock Information
- Founded
- RLGT 2001
- XOMA 1981
- Country
- RLGT United States
- XOMA United States
- Employees
- RLGT N/A
- XOMA N/A
- Industry
- RLGT Oil Refining/Marketing
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- XOMA Health Care
- Exchange
- RLGT Nasdaq
- XOMA Nasdaq
- Market Cap
- RLGT 301.7M
- XOMA 319.3M
- IPO Year
- RLGT N/A
- XOMA N/A
- Fundamental
- Price
- RLGT $6.88
- XOMA $23.52
- Analyst Decision
- RLGT
- XOMA Strong Buy
- Analyst Count
- RLGT 0
- XOMA 2
- Target Price
- RLGT N/A
- XOMA $72.00
- AVG Volume (30 Days)
- RLGT 150.5K
- XOMA 58.5K
- Earning Date
- RLGT 02-10-2025
- XOMA 03-07-2025
- Dividend Yield
- RLGT N/A
- XOMA N/A
- EPS Growth
- RLGT 32.26
- XOMA N/A
- EPS
- RLGT 0.29
- XOMA N/A
- Revenue
- RLGT $858,699,000.00
- XOMA $21,606,000.00
- Revenue This Year
- RLGT $12.86
- XOMA $511.37
- Revenue Next Year
- RLGT $5.75
- XOMA $26.92
- P/E Ratio
- RLGT $23.78
- XOMA N/A
- Revenue Growth
- RLGT N/A
- XOMA 389.82
- 52 Week Low
- RLGT $4.83
- XOMA $21.27
- 52 Week High
- RLGT $7.94
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- RLGT 44.48
- XOMA 33.53
- Support Level
- RLGT $7.13
- XOMA $24.01
- Resistance Level
- RLGT $7.88
- XOMA $27.43
- Average True Range (ATR)
- RLGT 0.28
- XOMA 1.15
- MACD
- RLGT -0.01
- XOMA -0.22
- Stochastic Oscillator
- RLGT 8.62
- XOMA 0.00
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.